(IBN) ICICI Bank - Ratings and Ratios
Retail Banking, Wholesale Banking, Treasury, Insurance, Mutual Funds
IBN EPS (Earnings per Share)
IBN Revenue
Description: IBN ICICI Bank September 25, 2025
ICICI Bank Limited (NYSE: IBN) and its subsidiaries deliver a broad suite of banking and financial services to retail and corporate clients in India and abroad, organized across Retail Banking, Wholesale Banking, Treasury, Life & General Insurance, and ancillary segments. Its product catalogue spans deposit accounts (savings, current, salary, pension, foreign-currency, VOSTRO), a full spectrum of consumer and SME loans (home, auto, education, gold, working-capital, collateral-free, and loan-against-securities), credit/debit/prepaid cards, digital wallets, wealth-management tools (mutual funds, IPO participation, demat services), and insurance solutions (life, health, motor, travel). The bank also offers corporate-level services such as cash-management, trade finance, capital-market activities, custodial and institutional banking, as well as merchant-banking, private-equity, and venture-capital fund management.
Key recent metrics (FY 2023-24) show a loan book of roughly ₹15.5 trillion, a net interest margin (NIM) of 4.2 %, and a CASA (current-account-savings-account) ratio of 53 %, reflecting strong low-cost funding. Non-performing assets (NPAs) have declined to 1.7 % of total advances, indicating improving asset quality. The bank’s capital adequacy ratio (CAR) stood at 15.3 %, comfortably above the RBI’s 12.5 % requirement. Growth drivers include India’s robust credit-expansion cycle (real-GDP growth projected at 6-7 % in FY 2024-25) and accelerated digital adoption, which has lifted mobile-banking transactions by over 30 % YoY. However, exposure to high-interest-rate environments and regulatory tightening on loan-to-value ratios remain material risks.
For a deeper, data-driven assessment of ICICI Bank’s valuation and risk profile, you may find the analytics on ValueRay worth exploring.
IBN Stock Overview
| Market Cap in USD | 110,195m |
| Sub-Industry | Diversified Banks |
| IPO / Inception | 1999-09-22 |
IBN Stock Ratings
| Growth Rating | 64.0% |
| Fundamental | 63.8% |
| Dividend Rating | 61.4% |
| Return 12m vs S&P 500 | -17.3% |
| Analyst Rating | 4.75 of 5 |
IBN Dividends
| Dividend Yield 12m | 0.82% |
| Yield on Cost 5y | 2.23% |
| Annual Growth 5y | 61.72% |
| Payout Consistency | 83.5% |
| Payout Ratio | 15.7% |
IBN Growth Ratios
| Growth Correlation 3m | -71.2% |
| Growth Correlation 12m | 55.1% |
| Growth Correlation 5y | 96.8% |
| CAGR 5y | 11.55% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.70 |
| CAGR/Mean DD 3y (Pain Ratio) | 2.37 |
| Sharpe Ratio 12m | -1.11 |
| Alpha | -12.36 |
| Beta | 0.407 |
| Volatility | 19.02% |
| Current Volume | 7037.6k |
| Average Volume 20d | 4120.6k |
| Stop Loss | 29.3 (-3.3%) |
| Signal | 0.15 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (533.00b TTM) > 0 and > 6% of Revenue (6% = 183.06b TTM) |
| FCFTA -0.03 (>2.0%) and ΔFCFTA -9.13pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -467.9% (prev -512.9%; Δ 44.99pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 1679.04b > Net Income 533.00b (YES >=105%, WARN >=100%) |
| Net Debt (48.60b) to EBITDA (1019.57b) ratio: 0.05 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.13 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (3.62b) change vs 12m ago 1.02% (target <= -2.0% for YES) |
| Gross Margin 68.62% (prev 67.35%; Δ 1.27pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 11.83% (prev 10.58%; Δ 1.25pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.93 (EBITDA TTM 1019.57b / Interest Expense TTM 907.88b) >= 6 (WARN >= 3) |
Altman Z'' -2.66
| (A) -0.54 = (Total Current Assets 2140.23b - Total Current Liabilities 16416.37b) / Total Assets 26422.41b |
| (B) 0.12 = Retained Earnings (Balance) 3104.11b / Total Assets 26422.41b |
| (C) 0.03 = EBIT TTM 843.79b / Avg Total Assets 25793.76b |
| (D) 0.27 = Book Value of Equity 6222.48b / Total Liabilities 23134.99b |
| Total Rating: -2.66 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.77
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield data missing |
| 3. FCF Margin -26.23% = -7.50 |
| 4. Debt/Equity 0.65 = 2.30 |
| 5. Debt/Ebitda 0.05 = 2.50 |
| 6. ROIC - WACC (= 3.88)% = 4.84 |
| 7. RoE 17.53% = 1.46 |
| 8. Rev. Trend 91.40% = 6.86 |
| 9. EPS Trend 86.36% = 4.32 |
What is the price of IBN shares?
Over the past week, the price has changed by -3.04%, over one month by +0.23%, over three months by -9.38% and over the past year by +0.43%.
Is ICICI Bank a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBN is around 28.33 USD . This means that IBN is currently overvalued and has a potential downside of -6.5%.
Is IBN a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the IBN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 40.1 | 32.2% |
| Analysts Target Price | 40.1 | 32.2% |
| ValueRay Target Price | 31.5 | 3.8% |
IBN Fundamental Data Overview November 01, 2025
P/E Trailing = 18.4012
P/E Forward = 19.084
P/S = 0.0577
P/B = 2.9488
Beta = 0.407
Revenue TTM = 3050.96b USD
EBIT TTM = 843.79b USD
EBITDA TTM = 1019.57b USD
Long Term Debt = 2188.83b USD (from longTermDebt, last fiscal year)
Short Term Debt = 226.22b USD (from shortTermDebt, last fiscal year)
Debt = 2036.50b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 48.60b USD (from netDebt column, last fiscal year)
Enterprise Value = 6.46b USD (110.19b + Debt 2036.50b - CCE 2140.23b)
Interest Coverage Ratio = 0.93 (Ebit TTM 843.79b / Interest Expense TTM 907.88b)
FCF Yield = -12.4k% (FCF TTM -800.22b / Enterprise Value 6.46b)
FCF Margin = -26.23% (FCF TTM -800.22b / Revenue TTM 3050.96b)
Net Margin = 17.47% (Net Income TTM 533.00b / Revenue TTM 3050.96b)
Gross Margin = 68.62% ((Revenue TTM 3050.96b - Cost of Revenue TTM 957.27b) / Revenue TTM)
Gross Margin QoQ = 69.89% (prev 66.59%)
Tobins Q-Ratio = 0.00 (Enterprise Value 6.46b / Total Assets 26422.41b)
Interest Expense / Debt = 10.81% (Interest Expense 220.17b / Debt 2036.50b)
Taxrate = 25.14% (48.08b / 191.26b)
NOPAT = 631.67b (EBIT 843.79b * (1 - 25.14%))
Current Ratio = 0.13 (Total Current Assets 2140.23b / Total Current Liabilities 16416.37b)
Debt / Equity = 0.65 (Debt 2036.50b / totalStockholderEquity, last fiscal year 3139.06b)
Debt / EBITDA = 0.05 (Net Debt 48.60b / EBITDA 1019.57b)
Debt / FCF = -0.06 (negative FCF - burning cash) (Net Debt 48.60b / FCF TTM -800.22b)
Total Stockholder Equity = 3040.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.02% (Net Income 533.00b / Total Assets 26422.41b)
RoE = 17.53% (Net Income TTM 533.00b / Total Stockholder Equity 3040.74b)
RoCE = 16.14% (EBIT 843.79b / Capital Employed (Equity 3040.74b + L.T.Debt 2188.83b))
RoIC = 11.94% (NOPAT 631.67b / Invested Capital 5290.82b)
WACC = 8.06% (E(110.19b)/V(2146.69b) * Re(7.51%) + D(2036.50b)/V(2146.69b) * Rd(10.81%) * (1-Tc(0.25)))
Discount Rate = 7.51% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.71%
Fair Price DCF = unknown (Cash Flow -800.22b)
EPS Correlation: 86.36 | EPS CAGR: 9.77% | SUE: 1.64 | # QB: 7
Revenue Correlation: 91.40 | Revenue CAGR: 18.40% | SUE: 0.90 | # QB: 12
Additional Sources for IBN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle